X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AANJANEYA LIFECARE with TTK HEALTHCARE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs TTK HEALTHCARE - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS TTK HEALTHCARE DR. DATSONS LABS/
TTK HEALTHCARE
 
P/E (TTM) x -10.9 26.7 - View Chart
P/BV x 0.2 5.9 2.8% View Chart
Dividend Yield % 0.0 0.5 -  

Financials

 DR. DATSONS LABS   TTK HEALTHCARE
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
TTK HEALTHCARE
Mar-14
DR. DATSONS LABS/
TTK HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs126663 18.9%   
Low Rs31399 7.7%   
Sales per share (Unadj.) Rs133.0535.6 24.8%  
Earnings per share (Unadj.) Rs0.215.9 1.0%  
Cash flow per share (Unadj.) Rs6.620.0 33.0%  
Dividends per share (Unadj.) Rs04.00 0.0%  
Dividend yield (eoy) %00.8 0.0%  
Book value per share (Unadj.) Rs128.8137.6 93.6%  
Shares outstanding (eoy) m31.667.77 407.5%   
Bonus/Rights/Conversions FCCB--  
Price / Sales ratio x0.61.0 59.3%   
Avg P/E ratio x516.133.3 1,549.3%  
P/CF ratio (eoy) x11.826.5 44.6%  
Price / Book Value ratio x0.63.9 15.7%  
Dividend payout %025.1 0.0%   
Avg Mkt Cap Rs m2,4774,127 60.0%   
No. of employees `000NA1.7 0.0%   
Total wages/salary Rs m56607 9.2%   
Avg. sales/employee Rs ThNM2,436.7-  
Avg. wages/employee Rs ThNM355.2-  
Avg. net profit/employee Rs ThNM72.5-  
INCOME DATA
Net Sales Rs m4,2114,162 101.2%  
Other income Rs m7961 128.6%   
Total revenues Rs m4,2894,223 101.6%   
Gross profit Rs m569197 288.5%  
Depreciation Rs m20432 644.8%   
Interest Rs m43030 1,438.8%   
Profit before tax Rs m13197 6.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m673 8.4%   
Profit after tax Rs m5124 3.9%  
Gross profit margin %13.54.7 285.1%  
Effective tax rate %48.037.0 129.8%   
Net profit margin %0.13.0 3.8%  
BALANCE SHEET DATA
Current assets Rs m6,8521,629 420.7%   
Current liabilities Rs m6,7111,058 634.4%   
Net working cap to sales %3.313.7 24.4%  
Current ratio x1.01.5 66.3%  
Inventory Days Days16130 540.2%  
Debtors Days Days31834 948.1%  
Net fixed assets Rs m3,673556 660.3%   
Share capital Rs m31778 407.5%   
"Free" reserves Rs m3,761878 428.2%   
Net worth Rs m4,0781,069 381.3%   
Long term debt Rs m1,671159 1,052.8%   
Total assets Rs m12,6332,399 526.5%  
Interest coverage x1.07.6 13.6%   
Debt to equity ratio x0.40.1 276.1%  
Sales to assets ratio x0.31.7 19.2%   
Return on assets %3.46.4 53.7%  
Return on equity %0.111.6 1.0%  
Return on capital %7.718.5 41.6%  
Exports to sales %22.90.8 2,896.2%   
Imports to sales %14.31.4 1,020.5%   
Exports (fob) Rs m96433 2,930.1%   
Imports (cif) Rs m60258 1,032.4%   
Fx inflow Rs m96433 2,930.1%   
Fx outflow Rs m60763 960.8%   
Net fx Rs m357-30 -1,178.3%   
CASH FLOW
From Operations Rs m1,345127 1,062.2%  
From Investments Rs m-2,256-146 1,544.9%  
From Financial Activity Rs m-1,20022 -5,478.5%  
Net Cashflow Rs m-2,1113 -84,428.0%  

Share Holding

Indian Promoters % 4.5 65.4 6.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 3.7 -  
FIIs % 1.4 5.2 26.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 25.8 364.7%  
Shareholders   20,807 12,723 163.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   JUBILANT LIFE SCIENCES  PANACEA BIOTECH  WOCKHARDT LTD.  GSK PHARMA  PLETHICO PHARMA  

Compare DR. DATSONS LABS With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Drops 230 Points as Trade War Fears Resurface(12:30 pm)

After opening the day flat, share markets in India witnessed choppy trading activity throughout the day and are presently below the dotted line.

Related Views on News

TTK HEALTHCARE Announces Quarterly Results (4QFY18); Net Profit Up 43.1%

Jun 14, 2018 | Updated on Jun 14, 2018

For the quarter ended March 2018, TTK HEALTHCARE has posted a net profit of Rs 80 m (up 43.1% YoY). Sales on the other hand came in at Rs 1 bn (up 21.4% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

Hindustan Aeronautics IPO: Yet Another Play on India's Defence Sector (IPO)

Mar 14, 2018

Should you apply for the IPO of state-run military aircraft maker Hindustan Aeronautics?

Bharat Dynamics IPO: Worth Betting on Defence Manufacturing? (IPO)

Mar 12, 2018

Should you apply for the IPO of Bharat Dynamics, India's first state-owned missile manufacturer?

Apollo Micro Systems Ltd. (IPO)

Jan 9, 2018

Should you subscribe to the IPO of Apollo Micro Systems Ltd?

Khadim India Ltd. (IPO)

Oct 31, 2017

Should you subscribe to the IPO of Khadim India Ltd?

More Views on News

Most Popular

After Vakrangee and Manpasand, More Auditors May Soon Resign. To Protect Your Wealth, Avoid these Stocks(The 5 Minute Wrapup)

Jun 8, 2018

The change in auditing regulations can bring a big change in corporate governance behaviour in the mid and small-cap space.

Should You Get out of Small Caps Now... Before the Fall Worsens(Profit Hunter)

Jun 6, 2018

An almost zero-loss strategy that works best when markets correct. Don't let the current volatility overwhelm you. Focus on the fundamentals and long term, and buy stocks where quality meets value.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Is Data Pointing Towards a Revival in the FMCG Sector?(Sector Info)

Jun 8, 2018

After several quarters of stress in the aftermath of demonetisation and the rollout of GST, this data is pointing towards revival in the India's rural FMCG industry.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS 8-QTR ANALYSIS

COMPARE DR. DATSONS LABS WITH

MARKET STATS